{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:10:19Z","timestamp":1780553419004,"version":"3.54.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1097\/adm.0000000000000214","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T16:27:34Z","timestamp":1466008054000},"page":"229-235","source":"Crossref","is-referenced-by-count":16,"title":["The Effect of Co-occurring Substance Use on Gamma-hydroxybutyric Acid Withdrawal Syndrome"],"prefix":"10.1097","volume":"10","author":[{"given":"Rama M.","family":"Kamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boukje A.G.","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton J.","family":"Loonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis A.J.","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210126","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/jcp.0b013e31815a2542","article-title":"Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users","volume":"27","author":"Abanades","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R2-3-20210126","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/13543780902905855","article-title":"The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data","volume":"18","author":"Addolorato","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"R3-3-20210126","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1360-0443.97.s1.1.x","article-title":"Subtypes of classifying adolescents with marijuana use disorders: Construct validity and clinical implications","volume":"97","author":"Babor","year":"2002","journal-title":"Addiction"},{"key":"R4-3-20210126","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuropharm.2010.05.011","article-title":"Withdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrus","volume":"59","author":"Barr","year":"2010","journal-title":"Neuropharmacology"},{"key":"R5-3-20210126","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bcp.2013.10.028","article-title":"GHB receptor targets in the CNS: Focus on high-affinity binding sites","volume":"87","author":"Bay","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"R6-3-20210126","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/02791072.2007.10400616","article-title":"Gamma-hydroxybutyric acid (GHB) withdrawal:a case report","volume":"39","author":"Bennett","year":"2007","journal-title":"J Psychoactive Drugs"},{"key":"R7-3-20210126","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0090-9556(25)07478-1","article-title":"Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride","volume":"21","author":"Cook","year":"1993","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"R8-3-20210126","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000333022","article-title":"Gamma-hydroxybutyrate detoxification by titration and tapering","volume":"18","author":"de Jong","year":"2012","journal-title":"Eur Addict Res"},{"key":"R9-3-20210126","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1360-0443.97.s01.2.x","article-title":"The cannabis youth treatment (CYT) experiment: rationale, study design and analysis plans","volume":"97","author":"Dennis","year":"2002","journal-title":"Addiction"},{"key":"R10-3-20210126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000097937","article-title":"Psychometric evaluation of the Dutch version of the Subjective Opiate Withdrawal Scale (SOWS)","volume":"13","author":"Dijkstra","year":"2007","journal-title":"Eur Addict Res"},{"key":"R11-3-20210126","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0024-3205(01)01526-0","article-title":"Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain","volume":"70","author":"Gobaille","year":"2002","journal-title":"Life Sci"},{"key":"R12-3-20210126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0269881105049041","article-title":"Gamma hydroxy butyrate abuse and dependency","volume":"19","author":"Gonzallez","year":"2005","journal-title":"J Psychopharmacol"},{"key":"R13-3-20210126","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00952998709001515","article-title":"Two new rating scales for opiate withdrawal","volume":"13","author":"Handelsman","year":"1987","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R15-3-20210126","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.ALC.0000057122.36127.C2","article-title":"Alcoholism: allostasis and beyond","volume":"27","author":"Koob","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"R16-3-20210126","first-page":"CD006266","article-title":"Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses","volume":"17","author":"Leone","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-3-20210126","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.drugalcdep.2005.07.010","article-title":"Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use","volume":"81","author":"Liechti","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"R18-3-20210126","first-page":"13","article-title":"Neurochemical mechanisms underlying alcohol withdrawal","volume":"22","author":"Littleton","year":"1998","journal-title":"Alcohol Health Res World"},{"key":"R19-3-20210126","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998","article-title":"Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428","volume":"18","author":"McCann","year":"1998","journal-title":"J Neurosci"},{"key":"R20-3-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2004.01.012","article-title":"Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review","volume":"75","author":"McDonough","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"R21-3-20210126","doi-asserted-by":"crossref","first-page":"iii16","DOI":"10.1136\/jnnp.2004.045708","article-title":"Alcohol and the nervous system","volume":"75","author":"McIntosh","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R23-3-20210126","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2013.08.014","article-title":"Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development","volume":"76","author":"Neisewander","year":"2014","journal-title":"Neuropharmacology"},{"key":"R24-3-20210126","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1192\/bjp.175.2.114","article-title":"Alcohol and the brain: pharmacological insights for psychiatrists","volume":"175","author":"Nutt","year":"1999","journal-title":"Br J Psychiatry"},{"key":"R25-3-20210126","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1360-0443.2009.02889.x","article-title":"Measurements in the Addictions for Triage and Evaluation (MATE): an instrument based on the World Health Organization family of international classifications","volume":"105","author":"Schippers","year":"2010","journal-title":"Addiction"},{"key":"R26-3-20210126","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1517\/14656566.2014.863278","article-title":"Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention","volume":"15","author":"Skala","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"R27-3-20210126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1124\/jpet.107.121798","article-title":"Benzodiazepine withdrawal-induced glutamatergic plasticity involves up-regulation of GluR1-containing alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in Hippocampal CA1 neurons","volume":"322","author":"Song","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R28-3-20210126","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1521-0391.2010.00099.x","article-title":"A web-based study of gamma hydroxybutyrate (GHB): patterns, experiences, and functions of use","volume":"20","author":"Stein","year":"2011","journal-title":"Am J Addict"},{"key":"R29-3-20210126","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopsych.2003.12.013","article-title":"Effects of sustained gamma-hydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons","volume":"55","author":"Szabo","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R30-3-20210126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yrtph.2012.03.005","article-title":"Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands","volume":"63","author":"van Amsterdam","year":"2012","journal-title":"Regul Toxicol Pharmacol"},{"key":"R31-3-20210126","first-page":"A1286","article-title":"Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment","volume":"154","author":"van Noorden","year":"2010","journal-title":"Nederlands tijdschrift voor geneeskunde"},{"key":"R32-3-20210126","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/386830a0","article-title":"Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature"},{"key":"R33-3-20210126","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1523\/JNEUROSCI.21-23-09414.2001","article-title":"Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence","volume":"21","author":"Volkow","year":"2001","journal-title":"J Neurosci"},{"key":"R35-3-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S1481803500010034","article-title":"Withdrawal from gamma-hydroxybutyrate,1,4-butanediol and gamma-butyrolactone: a case report and systematic review","volume":"10","author":"Wojtowicz","year":"2008","journal-title":"CJEM"},{"key":"R36-3-20210126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tips.2003.11.001","article-title":"From the street to the brain: neurobiology of the recreational drug \u03b3-hydroxybutyric acid","volume":"25","author":"Wong","year":"2004","journal-title":"Trends Pharmacol Sci"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ADM.0000000000000214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T21:49:42Z","timestamp":1748987382000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01271255-201608000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0000000000000214","relation":{},"ISSN":["1932-0620"],"issn-type":[{"value":"1932-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}